Fibrous palygorskite clays as versatile nanocarriers for skin delivery of tea tree oils in efficient acne therapy. 2022

Zhaolun Zhang, and Xi Zhang, and Zhengpeng Fu, and Lihua Cao, and Ziyi Xiong, and Ying Tang, and Yongjun Feng
Beijing Key Laboratory of Plant Resources Research and Development, College of Chemistry and Materials Engineering, Beijing Technology and Business University, Beijing 100048, China.

This paper presents a facile approach to develop palygorskite (Pal), a fibrous clay mineral, as a delivery system of tea tree oil (TTO) for topical acne therapy. The obtained TTO-Pal composite showed an efficient loading of TTO (27.4%) with a selective accumulation of terpine-4-ol and 1,8-cineole (two major antimicrobial TTO constituents), sustained release of TTO at skin physiological conditions (pH5.4, 32 °C) and superior skin sebum (2.2 g/g) absorbability. In vitro toxicological assessments showed that the Pal incorporation strategy significantly reduced the acute contact toxicity of TTO. The antimicrobial results revealed a preferable bacteriostatic effect for the TTO-Pal system towards opportunistic dermal pathogens (Escherichia coli, Staphylococcus aureus and Propionibacterium acnes) over the beneficial bacterium (Staphylococcus epidermis). Moreover, TTO-Pal based formulations exhibited pronounced clinical therapeutic efficacy in treating facial acne by rapidly reducing inflamed lesions, modulating skin sebum overproduction and restoring barrier function. This is the first report of using fibrous clay as a biocompatible nanocarrier system for topical delivery of essential oils in efficient management of facial acne with both in vitro and in vivo evidences, which may open perspectives for fibrous clay-drug delivery system in topical application and expand the high added value development of this mineral resource in the advanced healthcare fields.

UI MeSH Term Description Entries
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077215 Clay A naturally-occurring rock or soil constituent characterized by particles with a diameter of less than 0.005 mm. It is composed primarily of hydrous aluminum silicates, trace amounts of metal OXIDES, and organic matter. Halloysite,Clays,Halloysites
D000152 Acne Vulgaris A chronic disorder of the pilosebaceous apparatus associated with an increase in sebum secretion. It is characterized by open comedones (blackheads), closed comedones (whiteheads), and pustular nodules. The cause is unknown, but heredity and age are predisposing factors. Acne
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013662 Tea The infusion of leaves of CAMELLIA SINENSIS (formerly Thea sinensis) as a beverage, the familiar Asian tea, which contains CATECHIN (especially epigallocatechin gallate) and CAFFEINE. Black Tea,Green Tea,Black Teas,Green Teas,Tea, Black,Tea, Green,Teas, Black,Teas, Green
D014197 Trees Woody, usually tall, perennial higher plants (Angiosperms, Gymnosperms, and some Pterophyta) having usually a main stem and numerous branches. Tree
D017616 Magnesium Compounds Inorganic compounds that contain magnesium as an integral part of the molecule. Compounds, Magnesium
D017655 Silicon Compounds Inorganic compounds that contain silicon as an integral part of the molecule. Compounds, Silicon
D020947 Tea Tree Oil Essential oil extracted from MELALEUCA ALTERNIFOLIA (tea tree). It is used as a topical antimicrobial due to the presence of terpineol. Aetheroleum Melaleucae alternifoliae,Melaleuca alternifolia Oil,Melaleucae alternifoliae, Aetheroleum,Oil, Melaleuca alternifolia,Oil, Tea Tree

Related Publications

Zhaolun Zhang, and Xi Zhang, and Zhengpeng Fu, and Lihua Cao, and Ziyi Xiong, and Ying Tang, and Yongjun Feng
April 2020, International journal of pharmaceutics,
Zhaolun Zhang, and Xi Zhang, and Zhengpeng Fu, and Lihua Cao, and Ziyi Xiong, and Ying Tang, and Yongjun Feng
February 2010, Nanomedicine : nanotechnology, biology, and medicine,
Zhaolun Zhang, and Xi Zhang, and Zhengpeng Fu, and Lihua Cao, and Ziyi Xiong, and Ying Tang, and Yongjun Feng
October 2013, Small (Weinheim an der Bergstrasse, Germany),
Zhaolun Zhang, and Xi Zhang, and Zhengpeng Fu, and Lihua Cao, and Ziyi Xiong, and Ying Tang, and Yongjun Feng
January 2020, Current pharmaceutical design,
Zhaolun Zhang, and Xi Zhang, and Zhengpeng Fu, and Lihua Cao, and Ziyi Xiong, and Ying Tang, and Yongjun Feng
November 2010, Journal of controlled release : official journal of the Controlled Release Society,
Zhaolun Zhang, and Xi Zhang, and Zhengpeng Fu, and Lihua Cao, and Ziyi Xiong, and Ying Tang, and Yongjun Feng
January 2018, Critical reviews in therapeutic drug carrier systems,
Zhaolun Zhang, and Xi Zhang, and Zhengpeng Fu, and Lihua Cao, and Ziyi Xiong, and Ying Tang, and Yongjun Feng
February 2015, Therapeutic delivery,
Zhaolun Zhang, and Xi Zhang, and Zhengpeng Fu, and Lihua Cao, and Ziyi Xiong, and Ying Tang, and Yongjun Feng
June 2021, Pharmaceutical research,
Zhaolun Zhang, and Xi Zhang, and Zhengpeng Fu, and Lihua Cao, and Ziyi Xiong, and Ying Tang, and Yongjun Feng
January 2014, Journal of biological engineering,
Zhaolun Zhang, and Xi Zhang, and Zhengpeng Fu, and Lihua Cao, and Ziyi Xiong, and Ying Tang, and Yongjun Feng
May 2024, Journal of nanobiotechnology,
Copied contents to your clipboard!